Online ISSN: 2331-4737
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

Restoring Our Ubiquitination Machinery to Overcome Cancer Therapy Resistance

Uncategorized

June 7, 2024
PRESS RELEASE: On May 6, 2024, a new editorial was published in Oncoscience, entitled, “Restoring our ubiquitination machinery to overcome resistance in cancer therapy.” continue reading »

PH-binding Motifs as a Platform for Drug Design: Lessons From Protease-activated Receptors (PARs)

News

May 24, 2024
PRESS RELEASE: On April 25, 2024, a new editorial was published in Oncoscience, entitled, “PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs.” continue reading »

The Price of Hope: CAR-T Therapy in Pediatric Leukemia

News

May 17, 2024
PRESS RELEASE: On April 25, 2024, a new editorial was published in Oncoscience, entitled, “The price of hope: CAR-T therapy in pediatric leukemia.” continue reading »

Therapeutic Opportunities for Hypermutated Urothelial Carcinomas Beyond Immunotherapy

News

May 10, 2024
PRESS RELEASE: On April 25, 2024, a new editorial was published in Oncoscience, entitled, “Therapeutic opportunities for hypermutated urothelial carcinomas beyond immunotherapy.” continue reading »